KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Receivables Refunds (2018 - 2024)

BioNTech SE's Receivables Refunds history spans 6 years, with the latest figure at $53.4 million for Q4 2024.

  • For Q4 2024, Receivables Refunds fell 72.27% year-over-year to $53.4 million; the TTM value through Dec 2024 reached $53.4 million, down 72.27%, while the annual FY2024 figure was $54.1 million, 72.07% down from the prior year.
  • Receivables Refunds for Q4 2024 was $53.4 million at BioNTech SE, down from $192.7 million in the prior quarter.
  • Across five years, Receivables Refunds topped out at $192.7 million in Q4 2023 and bottomed at $408098.9 in Q4 2022.
  • The 5-year median for Receivables Refunds is $1.1 million (2020), against an average of $49.6 million.
  • The largest annual shift saw Receivables Refunds plummeted 87.14% in 2020 before it surged 47119.15% in 2023.
  • A 5-year view of Receivables Refunds shows it stood at $1.1 million in 2020, then plummeted by 57.36% to $457588.4 in 2021, then decreased by 10.82% to $408098.9 in 2022, then soared by 47119.15% to $192.7 million in 2023, then plummeted by 72.27% to $53.4 million in 2024.
  • Per Business Quant, the three most recent readings for BNTX's Receivables Refunds are $53.4 million (Q4 2024), $192.7 million (Q4 2023), and $408098.9 (Q4 2022).